FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration.

Autor:	Cabrera-Martín MN; Department of Neurology, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Nespral P; Department of Neurology, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Valles-Salgado M; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Bascuñana P; Department of Neurology, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Delgado-Alonso C; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Delgado-Álvarez A; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Fernández-Romero L; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., López-Carbonero JI; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Díez-Cirarda M; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Gil-Moreno MJ; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Matías-Guiu J; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain., Matias-Guiu JA; Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain.
Jazyk:	angličtina
Zdroj:	Frontiers in psychology [Front Psychol] 2023 Nov 16; Vol. 14, pp. 1273608. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
DOI:	10.3389/fpsyg.2023.1273608
Abstrakt:	Introduction: The Addenbrooke's Cognitive Examination III (ACE-III) is a brief test useful for neuropsychological assessment. Several studies have validated the test for the diagnosis of Alzheimer's disease (AD) and frontotemporal dementia (FTD). In this study, we aimed to examine the metabolic correlates associated with the performance of ACE-III in AD and behavioral variant FTD. Methods: We enrolled 300 participants in a cross-sectional study, including 180 patients with AD, 60 with behavioral FTD (bvFTD), and 60 controls. An 18 F-Fluorodeoxyglucose positron emission tomography study was performed in all cases. Correlation between the ACE-III and its domains (attention, memory, fluency, language, and visuospatial) with the brain metabolism was estimated. Results: The ACE-III showed distinct neural correlates in bvFTD and AD, effectively capturing the most relevant regions involved in these disorders. Neural correlates differed for each domain, especially in the case of bvFTD. Lower ACE-III scores were associated with more advanced stages in both disorders. The ACE-III exhibited high discrimination between bvFTD vs. HC, and between AD vs. HC. Additionally, it was sensitive to detect hypometabolism in brain regions associated with bvFTD and AD. Conclusion: Our study contributes to the knowledge of the brain regions associated with ACE-III, thereby facilitating its interpretation, and highlighting its suitability for screening and monitoring. This study provides further validation of ACE-III in the context of AD and FTD. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision. (Copyright © 2023 Cabrera-Martín, Nespral, Valles-Salgado, Bascuñana, Delgado-Alonso, Delgado-Álvarez, Fernández-Romero, López-Carbonero, Díez-Cirarda, Gil-Moreno, Matías-Guiu and Matias-Guiu.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu